ACAD vs EWTX
ACADIA Pharmaceuticals Inc. · Edgewise Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | ACAD | EWTX |
|---|---|---|
| Price | $28.45 | $44.42 |
| Market Cap | $4.87B | $4.78B |
| P/E | 12.46 | — |
| P/B | 3.90 | 9.69 |
| P/S | 4.55 | — |
| ROE | 31.3% | -34.0% |
| Net Margin | 36.5% | — |
| Gross Margin | 63.9% | — |
| Revenue Growth | 11.9% | — |
| Dividend Yield | — | — |
| EPS | $2.28 | -$1.56 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.